Many modern drugs are based on antibodies. These proteins very specifically identify a certain structure on the surface of ...
A new Consumer Reports investigation of infant formulas found that some of the products tested contained potentially harmful ...
Updated results from BP1001-A obesity and Type 2 diabetes testing from the second stage of pre-clinical testing are as follows: Previously, Bio-Path reported BP1001-A increased insulin sensitivity in ...
Dr. Reddy’s Laboratories (NYSE:RDY) and Alvotech (NASDAQ:ALVO) announced that the U.S. FDA has accepted a Biologic License Application submission for AVT03, which is a proposed biosimilar of Prolia ...